BAJAJ BROKING

Notification
No new Notification messages
Tankup Engineers IPO is Open!
Apply for the Tankup Engineers IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

1508

540975

ASTERDM

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

ASTER DM HEALTHCARE LTD. performance

Today’s low

Today’s high

₹ 494.25 ₹ 515.50
₹ 501.85

52 week low

52 week high

₹ 311.10 ₹ 534.80
₹ 501.85

Open Price

₹ 513.00

Prev. Close

₹ 508.90

Volume (Shares)

194127.00

Total traded value

₹ 974.22

Upper Circuit

₹ 610.65

Lower Circuit

₹ 407.15

info

ASTER DM HEALTHCARE LTD. Share Price Update

As of the latest trading session, ASTER DM HEALTHCARE LTD. share price is currently at ₹ 495.35, which is down by -13.54 from its previous closing. Today, the stock has fluctuated between ₹ 494.25 and ₹ 515.50. Over the past year, ASTER DM HEALTHCARE LTD. has achieved a return of 32.73 %. In the last month alone, the return has been 16.72 %. Read More...

ASTER DM HEALTHCARE LTD. fundamentals


  • Market cap (Cr)

    24,742.73

  • P/E Ratio (TTM)

    4.15

  • Beta

    0.55

  • Book Value / share

    67.47

  • Return on equity

    5.62%

  • EPS (TTM)

    115.83

  • Dividend yield

    0.39%

  • Net profit/quarter (Cr)

    49.82

info icon alternate text
  • Market cap (Cr)

    24,702.77

  • P/E Ratio (TTM)

    4.15

  • Beta

    0.53

  • Book Value / share

    67.47

  • Return on equity

    5.62%

  • EPS (TTM)

    115.83

  • Dividend yield

    0.39%

  • Net profit/quarter (Cr)

    49.82

info icon alternate text

ASTER DM HEALTHCARE LTD. Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 576.32
Operating Expense 522.15
Net Profit 49.82
Net Profit Margin (%) 8.64
Earnings Per Share (EPS) 1.00
EBITDA 125.42
Effective Tax Rate (%) 27.08
Particulars SEP 2024 (Values in Cr)
Revenue 604.68
Operating Expense 531.59
Net Profit 89.84
Net Profit Margin (%) 14.85
Earnings Per Share (EPS) 1.80
EBITDA 175.73
Effective Tax Rate (%) 25.02
Particulars JUN 2024 (Values in Cr)
Revenue 565.62
Operating Expense 520.34
Net Profit 6008.24
Net Profit Margin (%) 1062.23
Earnings Per Share (EPS) 120.67
EBITDA 6093.56
Effective Tax Rate (%) 0.48
Particulars MAR 2024 (Values in Cr)
Revenue 545.56
Operating Expense 502.63
Net Profit -8.11
Net Profit Margin (%) -1.48
Earnings Per Share (EPS) -0.16
EBITDA 103.22
Effective Tax Rate (%) 117.38
Particulars DEC 2023 (Values in Cr)
Revenue 524.50
Operating Expense 484.64
Net Profit 53.19
Net Profit Margin (%) 10.14
Earnings Per Share (EPS) 1.07
EBITDA 104.83
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 2036.50
Operating Expense 1876.17
Net Profit 156.96
Net Profit Margin (%) 7.70
Earnings Per Share (EPS) 3.15
EBITDA 409.10
Effective Tax Rate (%) 25.02
Particulars MAR 2023 (Values in Cr)
Revenue 1533.74
Operating Expense 1401.17
Net Profit 173.29
Net Profit Margin (%) 11.29
Earnings Per Share (EPS) 3.48
EBITDA 338.16
Effective Tax Rate (%) 4.95
Particulars MAR 2022 (Values in Cr)
Revenue 1116.47
Operating Expense 1108.71
Net Profit 90.18
Net Profit Margin (%) 8.07
Earnings Per Share (EPS) 1.81
EBITDA 232.70
Effective Tax Rate (%) -0.24
Particulars MAR 2021 (Values in Cr)
Revenue 746.54
Operating Expense 836.21
Net Profit -68.78
Net Profit Margin (%) -9.21
Earnings Per Share (EPS) -1.38
EBITDA 63.45
Effective Tax Rate (%) -1.08
Particulars MAR 2020 (Values in Cr)
Revenue 760.42
Operating Expense 810.32
Net Profit 60.61
Net Profit Margin (%) 7.97
Earnings Per Share (EPS) 1.21
EBITDA 187.13
Effective Tax Rate (%) 6.19
Particulars MAR 2024 (Values in Cr)
Book Value / Share 75.42
ROE % 5.70
ROCE % 4.78
Total Debt to Total Equity 0.87
EBITDA Margin 16.41
Particulars MAR 2023 (Values in Cr)
Book Value / Share 73.19
ROE % 13.14
ROCE % 2.96
Total Debt to Total Equity 1.33
EBITDA Margin 16.14
Particulars MAR 2022 (Values in Cr)
Book Value / Share 71.65
ROE % 17.05
ROCE % 10.51
Total Debt to Total Equity 1.33
EBITDA Margin 15.45
Particulars MAR 2021 (Values in Cr)
Book Value / Share 60.32
ROE % 5.10
ROCE % 5.88
Total Debt to Total Equity 1.57
EBITDA Margin 13.43
Particulars MAR 2020 (Values in Cr)
Book Value / Share 58.33
ROE % 14.20
ROCE % 11.22
Total Debt to Total Equity 1.29
EBITDA Margin 17.37
Particulars MAR 2024 (Values in Cr)
Book Value / Share 57.38
ROE % 5.62
ROCE % 7.37
Total Debt to Total Equity 0.24
EBITDA Margin 20.34
Particulars MAR 2023 (Values in Cr)
Book Value / Share 54.10
ROE % 6.36
ROCE % 6.40
Total Debt to Total Equity 0.20
EBITDA Margin 22.35
Particulars MAR 2022 (Values in Cr)
Book Value / Share 51.67
ROE % 3.23
ROCE % 3.93
Total Debt to Total Equity 0.16
EBITDA Margin 21.09
Particulars MAR 2021 (Values in Cr)
Book Value / Share 50.09
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.13
EBITDA Margin 8.50
Particulars MAR 2020 (Values in Cr)
Book Value / Share 51.45
ROE % 1.92
ROCE % 2.81
Total Debt to Total Equity 0.08
EBITDA Margin 24.61
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 112.65
Total Assets 17991.31
Total Liabilities 17991.31
Total Equity 5030.11
Share Outstanding 499500000
Price to Book Ratio 7.13
Return on Assets (%) 0.71
Return on Capital (%) 2.27
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 428.56
Total Assets 14881.20
Total Liabilities 14881.20
Total Equity 4860.46
Share Outstanding 499500000
Price to Book Ratio 4.46
Return on Assets (%) 2.85
Return on Capital (%) 5.94
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 379.61
Total Assets 12546.24
Total Liabilities 12546.24
Total Equity 4482.62
Share Outstanding 499500000
Price to Book Ratio 3.81
Return on Assets (%) 4.19
Return on Capital (%) 7.88
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 281.36
Total Assets 11643.46
Total Liabilities 11643.46
Total Equity 3834.12
Share Outstanding 497000000
Price to Book Ratio 2.74
Return on Assets (%) 1.26
Return on Capital (%) 2.4
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 177.12
Total Assets 12437.84
Total Liabilities 12437.84
Total Equity 3718.51
Share Outstanding 496800000
Price to Book Ratio 1.86
Return on Assets (%) 2.22
Return on Capital (%) 4.46
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 34.85
Total Assets 4537.73
Total Liabilities 4537.73
Total Equity 3294.24
Share Outstanding 499500000
Price to Book Ratio 7.13
Return on Assets (%) 3.45
Return on Capital (%) 4.26
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 31.29
Total Assets 4102.07
Total Liabilities 4102.07
Total Equity 3130.56
Share Outstanding 499500000
Price to Book Ratio 4.46
Return on Assets (%) 4.22
Return on Capital (%) 4.99
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 25.02
Total Assets 3762.00
Total Liabilities 3762.00
Total Equity 2955.21
Share Outstanding 499500000
Price to Book Ratio 3.81
Return on Assets (%) 2.39
Return on Capital (%) 2.86
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 17.59
Total Assets 3588.62
Total Liabilities 3588.62
Total Equity 2864.11
Share Outstanding 497000000
Price to Book Ratio 2.74
Return on Assets (%) -1.91
Return on Capital (%) -2.27
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 33.39
Total Assets 3553.00
Total Liabilities 3553.00
Total Equity 2930.60
Share Outstanding 496800000
Price to Book Ratio 1.86
Return on Assets (%) 1.70
Return on Capital (%) 1.97
Particulars MAR 2024 (Values in Cr)
Net Income 330.30
Cash from Operations 229.07
Cash from Investing -884.65
Cash from Financing 1052.83
Net change in Cash 325.99
Free Cash Flow 1025.98
Particulars MAR 2023 (Values in Cr)
Net Income 535.09
Cash from Operations 1892.93
Cash from Investing -971.88
Cash from Financing -817.39
Net change in Cash 44.71
Free Cash Flow 2609.78
Particulars MAR 2022 (Values in Cr)
Net Income 636.85
Cash from Operations 1371.16
Cash from Investing -570.48
Cash from Financing -686.00
Net change in Cash 57.56
Free Cash Flow 1854.20
Particulars MAR 2021 (Values in Cr)
Net Income 205.05
Cash from Operations 1580.17
Cash from Investing -330.30
Cash from Financing -1116.13
Net change in Cash 122.69
Free Cash Flow 1984.43
Particulars MAR 2020 (Values in Cr)
Net Income 330.04
Cash from Operations 1288.93
Cash from Investing -667.28
Cash from Financing -674.80
Net change in Cash -118.83
Free Cash Flow 1812.80
Particulars MAR 2024 (Values in Cr)
Net Income 209.35
Cash from Operations 444.50
Cash from Investing -342.32
Cash from Financing -67.09
Net change in Cash 3.34
Free Cash Flow 659.27
Particulars MAR 2023 (Values in Cr)
Net Income 182.33
Cash from Operations 261.63
Cash from Investing -331.95
Cash from Financing 92.20
Net change in Cash 6.11
Free Cash Flow 419.16
Particulars MAR 2022 (Values in Cr)
Net Income 89.96
Cash from Operations 82.74
Cash from Investing -49.17
Cash from Financing -17.69
Net change in Cash 11.48
Free Cash Flow 128.73
Particulars MAR 2021 (Values in Cr)
Net Income -68.78
Cash from Operations 51.13
Cash from Investing -38.07
Cash from Financing -12.35
Net change in Cash -8.76
Free Cash Flow 95.63
Particulars MAR 2020 (Values in Cr)
Net Income 64.61
Cash from Operations 119.42
Cash from Investing 39.75
Cash from Financing -125.70
Net change in Cash 12.05
Free Cash Flow 232.05
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7161.00 78.59 13.74 102964.19 5690.80 / 7545.10
FORTIS MALAR HOSPITALS LIMITED 78.38 191.17 4.92 146.90 51.01 / 98.70
SHREE PACETRONIX LTD. 70.50 14.69 1.88 25.38 61.11 / 268.50
TRANSGENE BIOTEK LTD. 3.90 0.00 2.72 29.55 3.22 / 10.84
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7161.00 85.68 12.57 102964.19 5690.80 / 7545.10
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 33.60 0.00 -17.99 25.10 28.34 / 59.90
KOVAI MEDICAL CENTER & HOSPITA 5598.45 29.67 6.29 6124.70 3750.00 / 6400.00

ASTER DM HEALTHCARE LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
501.85 -1.38 redarrow
red-green-graph indicator
2 Bearish
14 Bullish
  • 5 Days 505.40
  • 26 Days 478.00
  • 10 Days 498.60
  • 50 Days 466.80
  • 12 Days 495.50
  • 100 Days 459.40
  • 20 Days 484.20
  • 200 Days 441.40
508.02 PIVOT

First Support

501.13

First Resistance

512.73

Second Support

496.42

Second Resistance

519.62

Third Support

489.53

Third Resistance

524.33

RSI

68.34

ADX

34.77

MACD

17.51

Williams % R

-10.42

Commodity Channel Index (CCI)

95.73

Date

2025-04-24

Week

217625.00

Same Day

196521.00

Month

524064.00

1 Year

0.56

3 Year

0.53

Over 1 Month

16.72%

down

Over 1 Year

32.73%

down

Over 3 Months

2.58%

down

Over 3 Years

38.28%

down

Over 6 Months

14.75%

down

Over 5 Years

37.31%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

ASTER DM HEALTHCARE LTD. shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
11.86%
Promoter Holdings
41.88%
FII
21.66%
DII
24.58%
Promoter Shares(Pledge Percentage)
40.67%
Name Shares Category
Union Investments Private Limited 1.8685381E8 (37.41%) Shareholding of Promoter and Promoter Group
Rimco (mauritius) Limited 4.2833467E7 (8.58%) Public Shareholding
Hdfc Small Cap Fund 3.4362768E7 (6.88%) Public Shareholding
Union (mauritius) Holdings Limited 1.9980522E7 (4.0%) Shareholding of Promoter and Promoter Group
Kotak Small Cap Fund 1.6962322E7 (3.4%) Public Shareholding
Smallcap World Fund, Inc 1.6332016E7 (3.27%) Public Shareholding
Franklin India Smaller Companies Fund 1.4582905E7 (2.92%) Public Shareholding
Sbi Contra Fund 1.1826151E7 (2.37%) Public Shareholding
Quant Mutual Fund - Quant Small Cap Fund 1.1337154E7 (2.27%) Public Shareholding
Rashid Aslam Bin Mohideen Mammu Haji 1.1225214E7 (2.25%) Public Shareholding
Nippon Life India Trustee Ltd-a/c Nippon India Small Cap Fund 9918633.0 (1.99%) Public Shareholding
Shamsudheen Bin Mohideenmammuhaji 5671732.0 (1.14%) Public Shareholding
Azad Moopen Mandayapurath 1733536.0 (0.35%) Shareholding of Promoter and Promoter Group
Alisha Moopen 244342.0 (0.05%) Shareholding of Promoter and Promoter Group
Naseera Azad 142587.0 (0.03%) Shareholding of Promoter and Promoter Group
Ziham Moopen 171500.0 (0.03%) Shareholding of Promoter and Promoter Group
Zeba Azad Moopen 108524.0 (0.02%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

ASTER DM HEALTHCARE LTD. corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
23 Apr 2024 118.0 Special 23 Apr 2024 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

Aster DM Share Result Highlights

MetricValue
Aster DM share price₹495.55
Net Profit (Qtr)₹89.84 Cr
Revenue (Qtr)₹604.68 Cr
Operating Expense₹531.59 Cr
Net Profit Margin14.85%
Earnings Per Share₹1.80
EBITDA₹175.73 Cr
Effective Tax Rate25.02%

Key Highlights

  • Aster DM share price has decreased by ₹4.40 in the latest session.
  • The company reported a net profit of ₹89.84 Cr with a margin of 14.85%.
  • EBITDA stands at ₹175.73 Cr, reflecting solid operational efficiency.
  • Revenue for the quarter is ₹604.68 Cr, indicating stable business performance.

Aster DM Share Annual Reports

MetricValue
Revenue (Annual)₹2036.50 Cr
Operating Expense₹1876.17 Cr
Net Profit (Annual)₹156.96 Cr
Net Profit Margin7.70%
Earnings Per Share₹3.15
EBITDA₹409.10 Cr
Effective Tax Rate25.02%

Key Highlights

  • Aster DM share price has performed steadily with a net profit of ₹156.96 Cr and a profit margin of 7.70%.
  • EBITDA for the year is ₹409.10 Cr, with healthy operational control.
  • Earnings Per Share (EPS) stood at ₹3.15 for the year, reflecting positive financial growth.

Aster DM Share Dividend

MetricValue
Dividend Yield0.40%
Dividend per ShareNot specified

Key Highlights

  • The Aster DM share price is accompanied by a modest dividend yield of 0.40%.
  • Although the company offers a dividend, the exact per-share amount has not been specified.
  • The low dividend yield suggests a focus on reinvestment into the business for growth.

Popular FAQs

1. Who is the CEO of Aster DM Healthcare Ltd?

The CEO of Aster DM Healthcare Ltd is Dr. Nitish Shetty, who was appointed as the Chief Executive Officer of Aster DM Healthcare India effective April 1, 2023. He has been instrumental in overseeing the company's operations in India and driving its growth strategy.

 

2. When was Aster DM Healthcare Ltd established?

Aster DM Healthcare Ltd was established in 1987. The company began as a single doctor clinic in Dubai and has since expanded significantly, developing a network of hospitals, clinics, pharmacies, and laboratories across multiple countries, including the GCC states and India.

 

3. What factors influence the Aster DM Share Price?

Several factors influence the Aster DM share price, including the company’s financial performance, growth prospects, and market conditions. The demand for healthcare services in the GCC and India, regulatory changes, competition in the healthcare sector, and developments within the company, such as acquisitions and expansions, also play a critical role in shaping its stock price.

 

4. Is Aster DM Healthcare Ltd debt-free?

No, Aster DM Healthcare Ltd is not completely debt-free. Like many large organizations, it uses a combination of debt and equity to finance its operations and expansion. However, the company’s debt levels and financial health are regularly monitored to ensure stability and growth, with a focus on maintaining a manageable debt burden.

 

5. What is the CAGR of Aster DM Share?

The Compound Annual Growth Rate (CAGR) of the Aster DM share price over the past five years is 26%, while over the past three years it is 37%. This indicates a strong upward trend in its stock performance, reflecting the company’s consistent growth and positive market sentiment towards its business model and expansion plans.

 

6. How has the Aster DM Share Price performed over the past year?

Over the past year, the Aster DM share price has shown a growth of 24%. This performance highlights the resilience of the company even in the face of economic challenges and reflects continued demand for its healthcare services across the regions it serves.

ASTER DM HEALTHCARE LTD. Share Price

Aster DM Healthcare Limited was erstwhile established as 'Aster DM Healthcare Private Limited', a private limited company on 18 January, 2008. On November 29, 2013. The Company was converted into a public limited company and the name of the Company was changed to Aster DM Healthcare Limited.

Aster DM Healthcare Limited is one of the leading healthcare player in the GCC and India. Founded in 1987 by Dr. Azad Moopen, the Company has emerged as an integrated healthcare service organization that provides the complete circle of care to people through network of hospitals, clinics, labs and pharmacies, providing primary, secondary, tertiary to quaternary care to all segments of the population.

Aster DM offer a diverse portfolio of specialised brands that serve patients in Primary, Secondary, Tertiary, and Quaternary Care, Healthcare Retailing, Diagnostic Laboratories, Digital Health, and Medical Education. With its patient-centric approach to medical care, the Company offer one of the largest and most widespread networks of Hospitals and Clinics, with the most premium healthcare facilities that aspire to make a difference.

Its hospitals in India are located in Kochi, Kolhapur, Kozhikode, Kottakkal, Bengaluru, Vijayawada, Guntur, Ongole, Wayanad and Hyderabad and are generally operated under the 'Aster', 'MIMS', 'Ramesh' or 'Prime' brands. The company has one of the largest and most widespread network of clinics across the Middle East. Their extensive network in India spans 19 hospitals, 13 clinics, 215 pharmacies and 232 labs and patient experience centres across five Indian states with a total bed capacity of 4,867 as on March 2024.

The Company commenced operations in 1987 as a single doctor clinic in Dubai established by the founder, Dr. Azad Moopen. Its first specialty medical centre was launched in Dubai in 1995. The Company's 'MIMS', or Malabar Institute of Medical Sciences, hospital in Kozhikode, Kerala, India, commenced operations in 2001. It started Qatar operations in 2003. In 2005, Al Rafa Hospital for Maternity and Surgery (now called Aster Day Surgery Centre LLC) commenced operations. In 2006, Medcare Hospital commenced operations.

The Company was incorporated in January 18, 2008 as DM Healthcare Private Limited on January 18, 2008 at Kochi, Ernakulam, Kerala, in a reorganisation to facilitate the growth of its operations, subsequent to which operations in the GCC states and India were consolidated under the Company.

In 2008, India Value Fund III A acquired 28.2% of the paid up Equity Share capital the company calculated at the time of investment. During the year under review, the company acquired majority stake in Prerana Hospital Limited (PHL), Kolhapur. In 2009, the company's Al Raffah Hospital located in Muscat, Oman, commenced operations. It extended its services to the Sultanate of Oman by establishing a medical centre in Sohar (ARMC) and a 30-bed hospital in Ghubra, Muscat.

In 2010, the company acquired 100% of the paid up equity share capital of Affinity Holdings Private Limited, Mauritius. During the year under review, the company's second Al Raffah Hospital in Oman commenced operations in Sohar. In 2011, the company's second Medcare Hospital, namely Medcare Orthopedics and Spine Hospital (Dubai) commenced operations.

In 2012, Olympus Capital Asia Investments Limited acquired 25.47% stake in the company. During the year under review, the company conditionally acquired 40.80% of the paid up equity share capital of Sanad Al Rahma for Medical Care LLC.

In 2013, the company acquired 60.35% of the paid up equity share capital of Indogulf Hospitals Private Limited (IHPL) and consequently Malabar Institute of Medical Sciences Limited (MIMS) became a subsidiary of the company.

The company acquired hospital operational and management rights in Aster CMC, Bangalore pursuant to the hospital operation and management agreement dated May 12, 2014. In August 2014, the company launched Aster Medcity in Kochi, Kerala, a multi-speciality hospital with a 670 bed capacity, to be positioned as a destination for medical value travel.

In 2014, the company acquired 51% voting rights in Sainatha Hospitals, Andhra Pradesh, 54% stake in Aster Kuwait for Medicine and Medical Supplied Company WLL and 51% stake in Orange Pharmacies LLC, Jordan. In 2015, the company's first clinic in the Kingdom of Bahrain and Philippines commenced operations.

In 2016, the company divested its stake in Medipoint Hospitals Private Limited, Pune. During the year under review, the company increased stake up to 70.68% in the paid up equity share capital of MIMS. During the year under review, the company increased stake up to 97% stake in Sanad Medical Care. During the year under review, the company acquired 51% stake in Dr Ramesh Hospital. During the year under review, the company's second clinic in Bahrain commenced operations. During the year under review, the company's Medcare Women and Child Hospital in Dubai became operational. During the year under review, the company launched its first multi-specialty hospital in Sharjah.

The company acquired hospital operational and management rights in DM Wayanad Institute of Medical Sciences, Wayanad pursuant to a medical services agreement and an operation and management agreement, both dated March 4, 2016.

In 2017, the company entered into an operation and management agreement with the Rashtreeya Sikshana Samithi Trust to operate and manage a hospital in Bengaluru. During the year under review, the company's Medare Hospital Sharjah and Aster Hospital Doha commenced operations.

On 9 April 2018, Aster DM Healthcare announced that it has entered into an agreement with Subramanya Constructions & Development Company Limited (SCDC), a leading real estate developer, to construct a new hospital in Chennai. This 500 bedded, state of the art, multi-specialty hospital is expected to commission in 2020. The hospital, which would be situated at a prime location in Chennai, will provide advanced healthcare services to the residents of Tamil Nadu and customers from other states in India as well as overseas.

During the year 2018, Aster Ramesh Duhita LLP, Dr. Moopens Aster Hospital WLL, Harley Street Dental LLC and Aster DCC Pharmacy LLC have become subsidiaries of the Company.

In Q4 FY19, Aster DM commenced Aster MIMS hospital, Kannur in the state of Kerala with bed capacity of 302 beds. It acquired Cedars Hospital in Dubia, UAE with bed capacity of 17 beds. It acquired Al Khair Hospital, in Ibri, Oman with bed capacity of 22 beds. Separate dedicated area for Physical Medicine and Rehabilitation was launched by Aster Medcity with capacity of 16 beds in Q3 FY19. It increased 150 beds with the acquisition of Ramesh Sanghamitra, Ongole under Aster Ramesh Hospitals.

As on March 31, 2020 the Company has 9 direct subsidiaries, 67 step-down subsidiaries and 4 associate companies. In FY 2020, Company unveiled teleMEDCARE, a unique telemedicine platform allowing patients to call doctors through video conferencing without the need for prior appointments, reaching quality healthcare to patients' homes. In partnership with Sharjah Health Authority, it launched a four-month cervical cancer awareness drive in Sharjah and the Northern Emirates in October 2019 to ensure early diagnosis and consultations from leading gynaecologists and medical practitioners. It launched a Centre of Excellence for Management of Endometriosis,
accredited by the British Society of Gynaecological Endoscopy, UK.

In FY'21, the Company had 76 subsidiaries and 7 associate companies. During FY 2021, Company was the first private healthcare player to introduce telemedicine in UAE and within 8 months enrolled 800 doctors consulting patients across the globe. It introduced home care services like doctors and nurses on call, vaccination and lab tests collection at home, delivery of prescription medicine at home which helped shift entire process of appointment booking to purchase of medicine to the homes of patients. Its homecare services were launched on a small scale, in tandem with the launch of teleMEDCARE in April 2020. Upon observing its performance, a dedicated team was hired, and the service officially launched in June 2020. Aster Hospital Al Qusais launched its dedicated Molecular Laboratory for COVID-19 PCR Testing with state-of-the-art facilities, highly qualified experts and very well trained nurses to provide accurate report less than 24 hours from testing. It introduced Cardio Thoracic Surgery and Neurosurgery & Centre of Excellence for Vitreo-retinal surgeries at Aster Hospital, Al Qusais.

As on March 31, 2022, the Company has 73 subsidiaries and 8 associate companies. Hindustan Pharma Distributors Private Limited become subsidiary of the Company during the year 2021-22. Aster DM Healthcare introduced a new structure in India with 5 clusters namely the Kerala, Karnataka and Maharashtra, Andhra and Telangana, Pharmacy and the Aster Labs in FY'22. It started a dedicated 77-bed women and children wing at Aster MIMS hospital in Kerala which added to existing 244-bed capacity at the facility. In Kolhapur, Maharashtra, it has operationalised 24 additional beds as part of Aster Aadhar Hospital's expansion. Recently in May 2022, it started operations at 140- bed Aster Mother Hospital in Areekode in Kerala. As of March 31, 2022, there were 2 Reference Labs, 12 Satellite Labs and 100 Patient Experience Centres (PEC). It acquired majority stake in Hindustan Pharma Distributors Private Limited and ventured into pharmacy business to optimize supply chain function of hospitals and franchised retail pharmacies. It signed an agreement with Alfaone Retail Pharmacies Private Limited (ARPPL) to license the Aster Pharmacy' brand to run retail stores and online pharmacy operations. During FY'22, ARPPL forayed into Telangana, Karnataka, and Kerala. As of March 31, 2022, there were 131 pharmacies, 82 in Karnataka, 27 in Kerala and 22 in Telangana serving 2.1 lakh customers in India. In June 2022, it announced the launch of the 550-bed Aster Capital Hospital at Trivandrum, Kerala. In April 2022, Aster DM Healthcare launched 101-bed multi-specialty Aster Hospital in Sharjah to cater to the needs of the people in Northern Emirates of the UAE. It signed a Memorandum of Understanding with The Government of Tamil Nadu which proposes an investment of Rs. 500 crore in hospitals, pharmacies and laboratories in the State.

The Company launched the 179 bed Aster Royal Hospital in Muscat, Oman and the 101 bed Aster Hospital in Sharjah in 2022-23. Aster India expanded its pharmacy network, reaching a milestone of 106 stores in Karnataka, 85 stores in Kerala, 61 stores in Telangana, and 5 stores in Andhra Pradesh by the end of FY23. Aster Labs increased its foot prints to 189 Patient Experience Centres (PEC), 15 Satellite Labs, and 1 Reference Lab.

Adiran IB Healthcare Private Limited, Komali Fertility Centre Ongole LLP, Cantown Infra Developers LLP and Zest Wellness Pharmacy LLC, became subsidiaries of the Company and Skin III Ltd became associate of the Company during the year 2022-23.

In 2024, the Company launched its Whitefield Hospital in Bangalore. It completed the segregation of the Gulf Corporation Council (GCC) business through the sale by Affinity Holdings Pvt Ltd, on April 03, 2024.

Parent organization Indian Private
NSE symbol ASTERDM
Founded 2008
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Aster DM Healthcare Ltd?

Answer Field

The share price of Aster DM Healthcare Ltd for NSE is ₹ 495.35 and for BSE is ₹ 494.55.

What is the Market Cap of Aster DM Healthcare Ltd?

Answer Field

The market cap of Aster DM Healthcare Ltd for NSE is ₹ 2,47,42.73 Cr. and for BSE is ₹ 2,47,02.77 Cr. as of now.

What is the 52 Week High and Low of Aster DM Healthcare Ltd?

Answer Field

The 52 Week High and Low of Aster DM Healthcare Ltd for NSE is ₹ 534.80 and ₹ 311.10 and for BSE is ₹ 534.00 and ₹ 312.25.

How to Buy Aster DM Healthcare Ltd share?

Answer Field

You can trade in Aster DM Healthcare Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Aster DM Healthcare Ltd?

Answer Field

The 1 year returns on the stock has been 32.73%.

What is the Current Share Price of Aster DM Healthcare Ltd?

Answer Field

Aster DM Healthcare Ltd share price is for NSE ₹ 495.35 & for BSE ₹ 494.55 as on Apr 25 2025 11:15 AM.

What is the Market Cap of Aster DM Healthcare Ltd Share?

Answer Field

The market cap of Aster DM Healthcare Ltd for NSE ₹ 2,47,42.73 & for BSE ₹ 2,47,02.77 as on Apr 25 2025 11:15 AM.

What is the P/E Ratio of Aster DM Healthcare Ltd Share?

Answer Field

As on Apr 25 2025 11:15 AM the price-to-earnings (PE) ratio for Aster DM Healthcare Ltd share is 4.15.

What is the PB ratio of Aster DM Healthcare Ltd Share?

Answer Field

As on Apr 25 2025 11:15 AM, the price-to-book (PB) ratio for Aster DM Healthcare Ltd share is 67.47.

How to Buy Aster DM Healthcare Ltd Share?

Answer Field

You can trade in Aster DM Healthcare Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Aster DM Healthcare Ltd Share on Bajaj Broking App?

Answer Field

To buy Aster DM Healthcare Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Aster DM Healthcare Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|